Advisory Committee on Organ Transplantation; Notice of Meeting, 10494 [2015-03929]
Download as PDF
<![CDATA[
10494
Federal Register / Vol. 80, No. 38 / Thursday, February 26, 2015 / Notices
Monday through Friday, and will be
posted to the docket at https://
www.regulations.gov.
Transcripts: As soon as a transcript is
available, FDA will post it at https://
wwww.fda.gov/NewsEvents/
MeetingsConferencesWorkshops/
ucm433552.htm.
Dated: February 20, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–03974 Filed 2–25–15; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
rmajette on DSK2VPTVN1PROD with NOTICES
Advisory Committee on Organ
Transplantation; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Committee on Organ
Transplantation (ACOT).
Date and Time: March 12, from 8:30
a.m. to 4:30 p.m. Eastern Standard
Time. March 13, from 8:30 a.m. to 12:30
p.m. Eastern Standard Time.
Place: Health Resources and Services
Administration, 5600 Fishers Lane,
Room 05W11, Rockville, MD 20857.
Status: The meeting will be open to
the public.
Purpose: Under the authority of 42
U.S.C. Section 217a, Section 222 of the
Public Health Service Act, as amended,
and 42 CFR 121.12 (2000), ACOT was
established to assist the Secretary in
enhancing organ donation, ensuring that
the system of organ transplantation is
grounded in the best available medical
science, and assuring the public that the
system is as effective and equitable as
possible, thereby increasing public
confidence in the integrity and
effectiveness of the transplantation
system. ACOT is composed of up to 25
members including the Chair. Members
serve as Special Government Employees
and have diverse backgrounds in fields
such as organ donation, health care
public policy, transplantation medicine
and surgery, critical care medicine, and
other medical specialties involved in
the identification and referral of donors,
non-physician transplant professions,
nursing, epidemiology, immunology,
law and bioethics, behavioral sciences,
economics and statistics, as well as
representatives of transplant candidates,
transplant recipients, organ donors, and
family members.
VerDate Sep<11>2014
15:27 Feb 25, 2015
Jkt 235001
Agenda: The Committee will hear
presentations, including those on the
following topics: Kidney Paired
Donation; Vascularized Composite
Allografts; Donor Management
Research; Living Donation; and the
Affordable Care Act and
Transplantation. Agenda items are
subject to change as priorities indicate.
After Committee discussions,
members of the public will have an
opportunity to comment. Because of the
Committee’s full agenda and timeframe
in which to cover the agenda topics,
public comment will be limited. All
public comments will be included in
the record of the ACOT meeting.
Meeting summary notes will be posted
on the Department’s organ donation
Web site at https://www.organdonor.gov/
legislation/advisory.html#meetings.
The draft meeting agenda will be
posted on www.blsmeetings.net/ACOT.
Those participating on this meeting
should pre-register by visiting
www.blsmeetings.net/ACOT. The
deadline to pre-register for this meeting
is Wednesday, March 11, 2015.
Registration will be confirmed on site.
For all logistical questions and
concerns, please contact Anita Allen,
Seamon Corporation at 301–658–3442
or send an email to aallen@
seamoncorporation.com.
Public Comment: It is preferred that
persons interested in providing an oral
presentation email a written request,
along with a copy of their presentation,
to Patricia Stroup, MBA, MPA,
Executive Secretary, Healthcare Systems
Bureau, Health Resources and Services
Administration, at pstroup@hrsa.gov.
Requests should contain the name,
address, telephone number, email
address, and any business or
professional affiliation of the person
desiring to make an oral presentation.
Groups having similar interests are
requested to combine their comments
and present them through a single
representative.
The allocation of time may be
adjusted to accommodate the level of
expressed interest. Persons who do not
file an advance request for a
presentation, but desire to make an oral
statement, may request it during the
public comment period. Public
participation and ability to comment
will be limited to time as it permits. FOR
FURTHER INFORMATION CONTACT: Patricia
Stroup, MBA, MPA, Executive
Secretary, Healthcare Systems Bureau,
Health Resources and Services
Administration, 5600 Fishers Lane,
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Room 17W65, Rockville, MD 20857;
telephone (301) 443–1127.
Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015–03929 Filed 2–25–15; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Emergency Clearance Request Human
Influenza Surveillance of Health Care
Centers in the United States and
Taiwan
In accordance with Section
3507(j) of the Paperwork Reduction Act
of 1995, the National Institute of Allergy
and Infectious Diseases (NIAID), the
National Institutes of Health (NIH), has
submitted to the Office of Management
and Budget (OMB) a request for
emergency review and processing of this
information collection by March 7,
2015. NIAID is requesting emergency
processing of this information
collection, pursuant to 5 CFR 1320.13,
because NIAID cannot reasonably
comply with the normal clearance
procedures which would cause a delay
and likely prevent or substantially
disrupt the collection of information. A
delay in starting the information
collection would hinder the agency in
accomplishing its mission to the
detriment of the public good. Public
harm could result through the loss of
critically needed information to
understand the causes of severity of
influenza and associated morbidity and
mortality during the Northern
hemisphere 2014–15 influenza season.
The National Institutes of Health may
not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number. Written comments and/or
suggestions from the public and affected
agencies are invited on one or more of
the following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
SUMMARY:
E:\FR\FM\26FEN1.SGM
26FEN1
]]>Agencies
[Federal Register Volume 80, Number 38 (Thursday, February 26, 2015)]
[Notices]
[Page 10494]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-03929]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Committee on Organ Transplantation; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: Advisory Committee on Organ Transplantation (ACOT).
Date and Time: March 12, from 8:30 a.m. to 4:30 p.m. Eastern
Standard Time. March 13, from 8:30 a.m. to 12:30 p.m. Eastern Standard
Time.
Place: Health Resources and Services Administration, 5600 Fishers
Lane, Room 05W11, Rockville, MD 20857.
Status: The meeting will be open to the public.
Purpose: Under the authority of 42 U.S.C. Section 217a, Section 222
of the Public Health Service Act, as amended, and 42 CFR 121.12 (2000),
ACOT was established to assist the Secretary in enhancing organ
donation, ensuring that the system of organ transplantation is grounded
in the best available medical science, and assuring the public that the
system is as effective and equitable as possible, thereby increasing
public confidence in the integrity and effectiveness of the
transplantation system. ACOT is composed of up to 25 members including
the Chair. Members serve as Special Government Employees and have
diverse backgrounds in fields such as organ donation, health care
public policy, transplantation medicine and surgery, critical care
medicine, and other medical specialties involved in the identification
and referral of donors, non-physician transplant professions, nursing,
epidemiology, immunology, law and bioethics, behavioral sciences,
economics and statistics, as well as representatives of transplant
candidates, transplant recipients, organ donors, and family members.
Agenda: The Committee will hear presentations, including those on
the following topics: Kidney Paired Donation; Vascularized Composite
Allografts; Donor Management Research; Living Donation; and the
Affordable Care Act and Transplantation. Agenda items are subject to
change as priorities indicate.
After Committee discussions, members of the public will have an
opportunity to comment. Because of the Committee's full agenda and
timeframe in which to cover the agenda topics, public comment will be
limited. All public comments will be included in the record of the ACOT
meeting. Meeting summary notes will be posted on the Department's organ
donation Web site at https://www.organdonor.gov/legislation/advisory.html#meetings.
The draft meeting agenda will be posted on www.blsmeetings.net/ACOT. Those participating on this meeting should pre-register by
visiting www.blsmeetings.net/ACOT. The deadline to pre-register for
this meeting is Wednesday, March 11, 2015. Registration will be
confirmed on site. For all logistical questions and concerns, please
contact Anita Allen, Seamon Corporation at 301-658-3442 or send an
email to aallen@seamoncorporation.com.
Public Comment: It is preferred that persons interested in
providing an oral presentation email a written request, along with a
copy of their presentation, to Patricia Stroup, MBA, MPA, Executive
Secretary, Healthcare Systems Bureau, Health Resources and Services
Administration, at pstroup@hrsa.gov. Requests should contain the name,
address, telephone number, email address, and any business or
professional affiliation of the person desiring to make an oral
presentation. Groups having similar interests are requested to combine
their comments and present them through a single representative.
The allocation of time may be adjusted to accommodate the level of
expressed interest. Persons who do not file an advance request for a
presentation, but desire to make an oral statement, may request it
during the public comment period. Public participation and ability to
comment will be limited to time as it permits. FOR FURTHER INFORMATION
CONTACT: Patricia Stroup, MBA, MPA, Executive Secretary, Healthcare
Systems Bureau, Health Resources and Services Administration, 5600
Fishers Lane, Room 17W65, Rockville, MD 20857; telephone (301) 443-
1127.
Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015-03929 Filed 2-25-15; 8:45 am]
BILLING CODE 4165-15-P
